Physician profile
Lyall Ashberg
NPI 1902854102
$21,107.42
in general payments reported to CMS, 2019-2025
11 companies · none reported in 2025
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $6,193 · 2020: $7,575 · 2021: $4,654 · 2022: $222 · 2023: $1,198 · 2024: $1,267.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Travel and Lodging: $1,811 · Food and Beverage: $654.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Travel and Lodging | $1,810.89 |
| Food and Beverage | $653.70 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Arthrex, INC. | $8,580.31 | 2019-2024 | |
| Smith+Nephew, INC. | $4,767.12 | 2019-2024 | Q-Fix, The Pink Hip Kit - Smith & Nephew Table, Evos |
| Southern Edge Orthopaedics, INC. | $3,230.00 | 2019-2021 | |
| Stryker Corporation | $2,066.18 | 2019-2023 | Salvation, Inspace, Na |
| Medwest Associates | $2,013.97 | 2021 | |
| Miach Orthopaedics, INC. | $181.21 | 2023 | |
| Djo, LLC | $149.47 | 2019 | |
| Linvatec Corporation | $43.48 | 2019 | |
| Vericel Corporation | $27.28 | 2022 | |
| Orthopediatrics Corp. | $26.51 | 2019 | |
| Davol INC. | $21.89 | 2021 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Lyall Ashberg listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.